Today's Rundown Featured Story | | | Wednesday, June 3, 2020 The Trump administration has selected its COVID-19 vaccine finalists for Operation Warp Speed, which aims to deliver safe and effective coronavirus vaccines to Americans by the end of the year, The New York Times reports. |
|
|---|
|
| | | Monday, May 25, 2020 Many elective procedures were postponed due to COVID-19, but with the Salesforce Accelerate Elective Procedures solution, providers are able to re-engage patients and reschedule elective procedures. |
|
|---|
|
Top Stories Wednesday, June 3, 2020 The FDA granted new COVID-19 green lights to Fitbit’s emergency ventilator alternative, as well as to a second device designed by engineers at NASA’s Jet Propulsion Laboratory. Tuesday, June 2, 2020 Infectious disease expert Anthony Fauci, M.D., says he believes a successful COVID-19 vaccine will not be a "one and done" and will require a booster dose to provide immunity. Here's what Fauci had to say about going to the ballot box and why a second wave is not inevitable. Wednesday, June 3, 2020 Novavax is racing against some of the world’s biggest pharmaceutical companies in its COVID-19 vaccine quest, and the biotech has now brought on a partner to manufacture its adjuvant. Wednesday, June 3, 2020 Follow along with the latest COVID-19 news straight from the FierceHealthcare team. Wednesday, June 3, 2020 The Trump administration revealed its Operation Warp Speed finalists, mostly favoring Big Pharma. Novavax recruited AGC Biologics to make COVID shot adjuvants. Valisure CEO David Light called for independent testing of foreign drugs as the pandemic strains FDA inspections. And an ex-Biogen staffer was arrested in Beijing for hiding COVID symptoms to enter China. Wednesday, June 3, 2020 After signing up to work with digital clinical trials firm Medable in May, Covance is setting up a new matchmaking service for COVID-19 trial participants. Wednesday, June 3, 2020 CMS outlined a series of changes and extensions to a series of value-based care payment models to help providers wracked by the COVID-19 pandemic. Wednesday, June 3, 2020 Launching an aesthetic product during COVID-19 sounds tricky, but Galderma’s looking on the bright side as it rolls out its newly approved Restylane Kysse lip filler. The lip augmentation product got the FDA green light last month and began shipping to aesthetician offices. Wednesday, May 20, 2020 The challenges of the COVID-19 pandemic have spurred many marketers to create reassuring and empathetic TV ads, including some pharma companies. Several pharmas have adjusted TV strategies to run, along with typical DTC or disease awareness commercials, ads that offer thanks to frontline healthcare workers or details about help to pay for medicine. |
|
